1 MONTELUKAST SODIUM | 160 of 1280 | 3950 prescriptions Less than 1% of all prescriptions | 3050 | 1120 patients 22% of all patients | 840 patients 17% of all patients | |
2 BREO ELLIPTA (FLUTICASONE/VILANTEROL) | 110 of 1130 | 2790 prescriptions Less than 1% of all prescriptions | 2230 | 620 patients 12% of all patients | 510 patients 10% of all patients | |
3 ADVAIR DISKUS (FLUTICASONE PROPION/SALMETEROL) | 140 of 1360 | 2200 prescriptions Less than 1% of all prescriptions | 1650 | 570 patients 11% of all patients | 450 patients 9% of all patients | |
4 PREDNISONE | 270 of 1390 | 2420 prescriptions Less than 1% of all prescriptions | 1780 | 930 patients 18% of all patients | 680 patients 13% of all patients | |
5 PROAIR HFA (ALBUTEROL SULFATE) | 140 of 1270 | 2420 prescriptions Less than 1% of all prescriptions | 1490 | 950 patients 19% of all patients | 680 patients 13% of all patients | |
6 SYMBICORT (BUDESONIDE/FORMOTEROL FUMARATE) | 240 of 1290 | 1490 prescriptions Less than 1% of all prescriptions | 930 | 420 patients 8% of all patients | 270 patients 5% of all patients | |
7 VENTOLIN HFA (ALBUTEROL SULFATE) | 100 of 1210 | 1990 prescriptions Less than 1% of all prescriptions | 1250 | 690 patients 14% of all patients | 490 patients 10% of all patients | |
8 STIOLTO RESPIMAT (TIOTROPIUM BR/OLODATEROL HCL) | 10 of 800 | 1240 prescriptions Less than 1% of all prescriptions | 800 | 280 patients 6% of all patients | < 11 | |
9 FLOVENT HFA (FLUTICASONE PROPIONATE) | 90 of 740 | 980 prescriptions Less than 1% of all prescriptions | 680 | 290 patients 6% of all patients | < 11 | |
10 SPIRIVA (TIOTROPIUM BROMIDE) | 420 of 1250 | 740 prescriptions Less than 1% of all prescriptions | 630 | 170 patients 3% of all patients | < 11 | |
11 SPIRIVA RESPIMAT (TIOTROPIUM BROMIDE) | 160 of 1070 | 1100 prescriptions Less than 1% of all prescriptions | 810 | 220 patients 4% of all patients | < 11 | |
12 ANORO ELLIPTA (UMECLIDINIUM BRM/VILANTEROL TR) | 370 of 1060 | 830 prescriptions Less than 1% of all prescriptions | 670 | 250 patients 5% of all patients | < 11 | |
13 AZITHROMYCIN | 290 of 1200 | 1110 prescriptions Less than 1% of all prescriptions | 920 | 510 patients 10% of all patients | < 11 | A |
14 ADVAIR HFA (FLUTICASONE PROPION/SALMETEROL) | 200 of 700 | 520 prescriptions Less than 1% of all prescriptions | | 120 patients 2% of all patients | < 11 | |
15 COMBIVENT RESPIMAT (IPRATROPIUM/ALBUTEROL SULFATE) | 70 of 510 | 420 prescriptions Less than 1% of all prescriptions | 220 | < 11 | < 11 | |
16 INCRUSE ELLIPTA (UMECLIDINIUM BROMIDE) | 340 of 1020 | 440 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
17 PULMICORT FLEXHALER (BUDESONIDE) | 20 of 140 | 280 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
18 DULERA (MOMETASONE/FORMOTEROL) | 40 of 340 | 370 prescriptions Less than 1% of all prescriptions | 120 | 110 patients 2% of all patients | < 11 | |
19 TRELEGY ELLIPTA (FLUTICASONE/UMECLIDIN/VILANTER) | 290 of 630 | 190 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
20 FLUCONAZOLE | 410 of 910 | 330 prescriptions Less than 1% of all prescriptions | 160 | 120 patients 2% of all patients | < 11 | |
21 THEOPHYLLINE ANHYDROUS | 110 of 310 | 220 prescriptions Less than 1% of all prescriptions | 220 | < 11 | < 11 | |
22 MOMETASONE FUROATE | 30 of 70 | 120 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
23 OMEPRAZOLE | 270 of 600 | 210 prescriptions Less than 1% of all prescriptions | 210 | < 11 | < 11 | |
24 FLUTICASONE PROPIONATE | 490 of 1030 | 190 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
25 LEVALBUTEROL TARTRATE HFA (LEVALBUTEROL TARTRATE) | 30 of 260 | 340 prescriptions Less than 1% of all prescriptions | 200 | < 11 | < 11 | |
26 PRAMIPEXOLE DIHYDROCHLORIDE (PRAMIPEXOLE DI-HCL) | 90 of 130 | 190 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
27 ZOLPIDEM TARTRATE | 200 of 370 | 220 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
28 XOLAIR (OMALIZUMAB) | 30 of 160 | 240 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
29 ADCIRCA (TADALAFIL) | 70 of 120 | 210 prescriptions Less than 1% of all prescriptions | 210 | < 11 | < 11 | |
30 ARNUITY ELLIPTA (FLUTICASONE FUROATE) | 290 of 510 | 140 prescriptions Less than 1% of all prescriptions | 140 | < 11 | < 11 | |
31 FUROSEMIDE | 360 of 590 | 160 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
32 PANTOPRAZOLE SODIUM | 130 of 410 | 160 prescriptions Less than 1% of all prescriptions | 160 | < 11 | < 11 | |
33 SILDENAFIL (SILDENAFIL CITRATE) | 100 of 150 | 110 prescriptions Less than 1% of all prescriptions | 110 | < 11 | < 11 | |
34 RIFAMPIN | 50 of 170 | 180 prescriptions Less than 1% of all prescriptions | 180 | < 11 | < 11 | |
35 BROVANA (ARFORMOTEROL TARTRATE) | 20 of 20 | 130 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
36 ALPRAZOLAM | 100 of 240 | 140 prescriptions Less than 1% of all prescriptions | 140 | < 11 | < 11 | |
37 BUDESONIDE | 30 of 30 | 120 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
38 ALBUTEROL SULFATE | 50 of 80 | 130 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
39 DOXYCYCLINE HYCLATE | 160 of 590 | 380 prescriptions Less than 1% of all prescriptions | | 220 patients 4% of all patients | < 11 | A |
40 DYMISTA (AZELASTINE/FLUTICASONE) | 50 of 80 | 110 prescriptions Less than 1% of all prescriptions | 110 | < 11 | < 11 | |
41 TUDORZA PRESSAIR (ACLIDINIUM BROMIDE) | 110 of 230 | 130 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
42 PROVENTIL HFA (ALBUTEROL SULFATE) | 20 of 30 | 140 prescriptions Less than 1% of all prescriptions | 140 | < 11 | < 11 | |
43 ATROVENT HFA (IPRATROPIUM BROMIDE) | 120 of 220 | 110 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
44 CEFUROXIME (CEFUROXIME AXETIL) | 40 of 40 | 180 prescriptions Less than 1% of all prescriptions | | 160 patients 3% of all patients | < 11 | A |